Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides
More topics under "C07K - Peptides" (616,656)
C07K 1 - General processes for the preparation of peptides (51,718)
C07K 11 - Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof (895)
C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
C07K 19 - Hybrid peptides (29,428)
C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102)
C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306)
Patents for C07K - Peptides (3,738)
07/1996
07/23/1996US5539063 Polymer for making poly(ethylene glycol)-protein conjugates
07/18/1996WO1996021463A2 New applications of lysozyme dimer
07/18/1996CA2210091A1 New applications of lysozyme dimer
07/17/1996EP0721343A1 Pharmaceutical formulations of nerve growth factor
06/1996
06/27/1996WO1996019483A1 Low molecular weight bicyclic thrombin inhibitors
06/27/1996CA2208772A1 Low molecular weight bicyclic thrombin inhibitors
06/25/1996US5529919 Method of making endoglucanase I
06/12/1996CN1124501A Anti-EGFR single-chain Fvs and anti-EGFR antibodies
05/1996
05/09/1996WO1996013266A1 Boronic ester and acid compounds, synthesis and uses
05/08/1996EP0517778B1 Vasoactive vasotocin derivatives
05/08/1996EP0365646B1 Synthetic peptides from streptococcal m protein and vaccines prepared therefrom
05/07/1996US5514585 Yeast processing system
05/02/1996WO1996012737A2 Compositions and treatment for multiple sclerosis
05/02/1996CA2203629A1 Compositions and treatment for multiple sclerosis
04/1996
04/25/1996WO1996011953A1 N-terminally chemically modified protein compositions and methods
04/25/1996CA2472085A1 N-terminally chemically modified protein compositions and methods
04/23/1996US5510249 Fusion of signal peptide, a leader peptide, a heterogenous protein or polypeptide; genetic engineering
04/18/1996WO1996011269A2 Tie-2 ligands, methods of making and uses thereof
04/11/1996WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof
04/09/1996US5506119 DNA encoding variant CD44 surface proteins associated with metastatic tumors
04/07/1996CA2159957A1 Regulated genes by stimulation of chondrocytes with il-1.beta.
04/04/1996WO1996010083A1 Novel pesticidal proteins and strains
03/1996
03/28/1996WO1996009060A1 Cell growth regulator
03/07/1996WO1995032291A3 Hepatitis g virus and molecular cloning thereof
03/06/1996EP0699079A1 Bioactive and/or targeted dendrimer conjugates
03/06/1996CN1031193C Polypeptide and method for preparing same
02/1996
02/22/1996WO1996005218A1 Delivery of nucleic acids
02/14/1996EP0696578A2 Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or blockers of calcium channels
02/14/1996CN1116847A N-(3-piperidinylcarbonyl)-beta-alanine derivatives as PAF antagonists
02/13/1996US5491088 Genetic engineering
02/07/1996EP0695355A1 Protein having tpo activity
02/07/1996EP0695189A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors
02/01/1996CA2195197A1 Corticotropin-releasing factor-binding-protein inhibitors and their use
01/1996
01/31/1996EP0694067A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite)
01/30/1996US5487984 Processes for producing tumor necrosis factor
01/02/1996CA1337861C De-acyl derivatives of antibiotic a 40926
12/1995
12/28/1995WO1995035320A1 High-affinity melatonin receptors and uses thereof
12/28/1995WO1995035311A1 3-amino-2-oxo-1-piperidineacetic derivatives as enzyme inhibitors
12/28/1995CA2193205A1 High-affinity melatonin receptors and uses thereof
12/27/1995EP0268663B1 Phosphopeptides
12/19/1995CA1337782C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
12/19/1995CA1337781C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
12/14/1995WO1995033772A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy
12/12/1995US5475087 Polypeptides
11/1995
11/30/1995WO1995032291A2 Hepatitis g virus and molecular cloning thereof
11/30/1995WO1995031990A1 Copolymer-1 improvements in compositions of copolymers
11/30/1995CA2190860A1 Hepatitis g virus and molecular cloning thereof
11/21/1995US5468480 Pharmaceutical composition of purified chymopapain
11/15/1995CN1111907A Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
10/1995
10/26/1995WO1995028419A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
10/26/1995CA2186900A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
10/18/1995EP0515415B1 Novel vaccine and method therefor
10/17/1995US5459236 Vasoactive vasotocin derivatives
10/11/1995EP0676470A1 Stem cell factor
10/11/1995EP0675904A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus
09/1995
09/22/1995CA2144936A1 Antibody conjugates with improved properties
09/20/1995EP0672057A1 Analogs of pth
09/20/1995EP0671928A1 Synthesis of n-substituted oligomers
09/14/1995WO1995024221A1 Bioactive and/or targeted dendrimer conjugates
09/06/1995EP0670332A2 Protein complexes having factor VIII:C activity and production thereof
09/06/1995EP0669912A1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists
08/1995
08/31/1995WO1995023167A1 Process for the obtention of a biological adhesive comprising fibrinogen, factor xiii and fibronectin
08/24/1995WO1995022557A1 Novel opioid peptides for the treatment of pain and use thereof
08/24/1995CA2181367A1 Novel opioid peptides for the treatment of pain and use thereof
08/23/1995EP0668351A1 Erythropoietin isoforms
08/17/1995WO1995021855A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
08/17/1995CA2180006A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
08/17/1995CA2160591A1 Protein having tpo activity
08/10/1995WO1995021254A1 Multivariant il-3 hematopoiesis fusion protein
08/10/1995WO1995020974A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides
08/10/1995CA2182484A1 Multivariant il-3 hematopoiesis fusion protein
08/10/1995CA2182369A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides
08/03/1995WO1995020605A1 Immuno-stimulatory monoclonal antibodies
08/02/1995CN1106021A Method for the separation of bacterial lipopolysaccharides from protein-containing solutions
08/01/1995CA1336529C Synthetic peptide antigens for the detection of htlv-1 infection
07/1995
07/27/1995WO1995019790A1 Humanized antibodies against leukocyte adhesion molecule vla-4
07/25/1995CA1336404C General cancer-associated scm-recognition factor, preparation and method of use
07/18/1995US5434131 Chimeric CTLA4 receptor and methods for its use
07/12/1995CN1105030A Erythropoietin analogs
07/04/1995US5430016 Insulin compounds and compositions
06/1995
06/28/1995EP0659439A2 Immunoconjugates
06/28/1995EP0659174A1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
06/27/1995US5428135 Production of platelet-derived growth factor B-chain heterodimers from high expression host cell system
06/07/1995EP0656012A1 T cell epitopes of ryegrass pollen allergen
05/1995
05/16/1995US5416194 Extracted from horseshoe crab
05/02/1995US5411887 From animal intestines using a proteolytic enzyme
04/1995
04/27/1995WO1995011045A1 Labeled chemotactic peptides to image focal sites of infection or inflammation
04/27/1995CA2173972A1 Labeled chemotactic peptides to image focal sites of infection or inflammation
04/12/1995EP0214971B1 Yeast strains producing cellulolytic enzymes and methods and means for constructing them
04/11/1995US5405324 Implantation device
04/05/1995EP0646127A1 Polypeptide bombesin antagonists
04/05/1995EP0646016A1 Synthetic peptides for the treatment of myasthenia gravis
03/1995
03/30/1995WO1995008536A1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists
03/29/1995EP0644948A1 Anti-receptor antibodies to the vitamin b12/transcobalamin ii receptor
03/28/1995CA1334942C Production of m-csf
03/08/1995EP0495013B1 Hexapeptides with sulphate ester groups
03/08/1995CN1099801A Peptides
03/07/1995US5395923 Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
03/07/1995US5395922 Yeast processing system
03/02/1995WO1995005845A1 Pharmaceutical formulations of nerve growth factor
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38